Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pancreatic Intraductal Neoplasms

• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
• Dachengqi Decoction for Enhancing Early Gastrointestinal Recovery After Whipple Surgery
• Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)
• The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
• DCE MRI in Patients With Pancreatic Cancer
• Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surge
• Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas
• Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery